BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1703 related articles for article (PubMed ID: 18282734)

  • 1. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
    Ball HJ; Sanchez-Perez A; Weiser S; Austin CJ; Astelbauer F; Miu J; McQuillan JA; Stocker R; Jermiin LS; Hunt NH
    Gene; 2007 Jul; 396(1):203-13. PubMed ID: 17499941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
    Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
    Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
    Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
    Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
    Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan metabolism along the kynurenine pathway in diet-induced and genetic hypercholesterolemic rabbits.
    Allegri G; Ragazzi E; Costa CV; Caparrotta L; Biasiolo M; Comai S; Bertazzo A
    Clin Chim Acta; 2004 Dec; 350(1-2):41-9. PubMed ID: 15530458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.
    Metz R; Duhadaway JB; Kamasani U; Laury-Kleintop L; Muller AJ; Prendergast GC
    Cancer Res; 2007 Aug; 67(15):7082-7. PubMed ID: 17671174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
    Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
    Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties.
    Austin CJ; Astelbauer F; Kosim-Satyaputra P; Ball HJ; Willows RD; Jamie JF; Hunt NH
    Amino Acids; 2009 Jan; 36(1):99-106. PubMed ID: 18274832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy.
    Ligam P; Manuelpillai U; Wallace EM; Walker D
    Placenta; 2005 Jul; 26(6):498-504. PubMed ID: 15950064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice.
    Liu L; Liu H; Mah C; Fletcher BS
    Gene Ther; 2009 Jun; 16(6):724-33. PubMed ID: 19262614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
    J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan.
    Yuasa HJ; Ball HJ; Austin CJ; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):10-5. PubMed ID: 20399882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
    Barry S; Clarke G; Scully P; Dinan TG
    J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.
    Fatokun AA; Hunt NH; Ball HJ
    Amino Acids; 2013 Dec; 45(6):1319-29. PubMed ID: 24105077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.